Queen Alexandra Hospital Opens Fecal Bank
|
By HospiMedica International staff writers Posted on 31 May 2016 |
|
Image: Clostridium difficile in a Petri dish (Photo courtesy of the University of Portsmouth).
Queen Alexandra Hospital (Portsmouth, United Kingdom) has opened a new frozen fecal bank, which could help cure for infections caused by Clostridium difficile.
The bank is part of a pilot project run by Robert Porter, MD, a consultant in microbiology and infection at Portsmouth Hospitals' NHS Trust (Portsmouth, United Kingdom). The bank will give patients across the United Kingdom access to screened frozen fecal material from a healthy donor in order to deliver healthy bacteria into the gut of a patient suffering from severe C. difficile infection.
The frozen samples, collected from pre-screened volunteers, can be stored for up to three months, and can be transported anywhere in the United Kingdom within hours, using overnight cold storage delivery; a single fecal transplant from the bank will cost about £85. The bank is funded by the Wessex Academic Health Science Network (Southhampton, United Kingdom), and supported by senior lecturer and researcher Carole Fogg, PhD, of the University of Portsmouth (Portsmouth, United Kingdom).
“Fecal transplants are extremely successful, and the impact on people's lives of such a simple treatment is difficult to overstate,” said Dr. Porter. “This is about something we all do every day potentially saving other people's lives. The pilot bank service also opens doors to new research, which we fully intend to take forward.”
Clostridium difficile is a bacterium that causes infection leading to diarrhea, and is most often related to antibiotic use during medical treatment. It is especially dangerous for patients with weakened immune systems such as the elderly and those with inflammatory bowel disease (IBD). Treatment includes antibiotics, probiotics, toxin-binding medications, active vaccination, and intravenous immunoglobon. About 20% of patients are resistant to these treatment and need a fecal microbiota transplant, which has a 96% cure rate.
Related Links:
Queen Alexandra Hospital
Portsmouth Hospitals' NHS Trust
Wessex Academic Health Science Network
University of Portsmouth
The bank is part of a pilot project run by Robert Porter, MD, a consultant in microbiology and infection at Portsmouth Hospitals' NHS Trust (Portsmouth, United Kingdom). The bank will give patients across the United Kingdom access to screened frozen fecal material from a healthy donor in order to deliver healthy bacteria into the gut of a patient suffering from severe C. difficile infection.
The frozen samples, collected from pre-screened volunteers, can be stored for up to three months, and can be transported anywhere in the United Kingdom within hours, using overnight cold storage delivery; a single fecal transplant from the bank will cost about £85. The bank is funded by the Wessex Academic Health Science Network (Southhampton, United Kingdom), and supported by senior lecturer and researcher Carole Fogg, PhD, of the University of Portsmouth (Portsmouth, United Kingdom).
“Fecal transplants are extremely successful, and the impact on people's lives of such a simple treatment is difficult to overstate,” said Dr. Porter. “This is about something we all do every day potentially saving other people's lives. The pilot bank service also opens doors to new research, which we fully intend to take forward.”
Clostridium difficile is a bacterium that causes infection leading to diarrhea, and is most often related to antibiotic use during medical treatment. It is especially dangerous for patients with weakened immune systems such as the elderly and those with inflammatory bowel disease (IBD). Treatment includes antibiotics, probiotics, toxin-binding medications, active vaccination, and intravenous immunoglobon. About 20% of patients are resistant to these treatment and need a fecal microbiota transplant, which has a 96% cure rate.
Related Links:
Queen Alexandra Hospital
Portsmouth Hospitals' NHS Trust
Wessex Academic Health Science Network
University of Portsmouth
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Wound Irrigation Solution
Prontosan®
New
X-Ray Generator
Advantage Plus Generators
Latest Hospital News News
- Nurse Tracking System Improves Hospital Workflow
- New Children’s Hospital Transforms California Healthcare
- Noisy Hospitals Face Threat of Decreased Federal Compensation
- Orthopedics Centre of Excellence Planned for Guy’s Hospital
- Research Suggests Avoidance of Low-Value Surgical Procedures
- U.S. Federal Readmission Fines Linked to Higher Mortality
- Columbia China to Build New Hospital in Jiaxing
- Dubai Debuts Second Robotic Pharmacy Service
- Seattle Hospital Network Shifts Away from Overlapping Surgeries
- ACC to Launch Valvular Heart Disease Program in China
- Mortality Rates Lower at Major Teaching Hospitals
- South Australia to Inaugurate Upscale Hospital
- Raffles to Launch Second Hospital Project in China
- Research Center Tackles Antimicrobial Drugs Challenge
- Miami Cardiac & Vascular Institute Completes Expansion Project
- Hospital Antibiotic Policies Improve Prescription Practices
Channels
Artificial Intelligence
view channel
AI Analysis of Pericardial Fat Refines Long-Term Heart Disease Risk
Accurately identifying long-term cardiovascular disease risk in asymptomatic adults remains challenging for clinicians. Missed or underestimated risk delays preventive therapy and increases the chance... Read more
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read more
Critical Care
view channel
Angiography-Based FFR Approach Matches Gold Standard Results Without Wires
Accurately determining whether a coronary stenosis limits blood flow is essential to guide percutaneous coronary intervention, yet wire-based physiologic testing remains underused due to added procedural... Read more
Eye Imaging AI Identifies Elevated Cardiovascular Risk
Many adults at risk for atherosclerotic cardiovascular disease are not identified until they undergo formal primary care assessment. Delayed risk recognition can postpone initiation of statins and lifestyle... Read more
Surgical Techniques
view channel
Fiber-Form Bone Graft Expands Intraoperative Options for Spinal Fusion
Spinal and orthopedic fusion procedures often require bone graft materials that handle predictably and support bone formation. Surgeons face added complexity in difficult anatomy and challenging fusion environments.... Read more
Ultrasound‑Aided Catheter Treatment Cuts Early Collapse in Pulmonary Embolism
Acute pulmonary embolism can cause rapid hemodynamic deterioration and early death in hospitalized and emergency patients. Systemic thrombolysis can dissolve clots but is limited by a high risk of major... Read more
Patient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Health IT
view channel
Voice-Driven AI System Enables Structured GI Procedure Documentation
Documentation during gastrointestinal (GI) procedures often competes with real-time clinical decision-making and imposes a significant cognitive burden on physicians. Manual data entry and post-procedure... Read more
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Business
view channel
GE HealthCare Leads Major European Initiative to Advance Cardio-Oncology Care
Cardiovascular complications are increasingly recognized among people undergoing or recovering from cancer treatment, driven by pre‑existing disease and the cardiotoxic effects of chemotherapy, radiotherapy,... Read more
